SeekingAlpha · Sep 11, 2026
HeartFlow, Inc. (HTFL) Presents at Wells Fargo 21st Annual Healthcare Conference - Slideshow
2026-09-11. The following slide deck was published by HeartFlow, Inc.
HT
NASDAQ · HTFL
Heartflow, Inc. Common Stock
Healthcare · Medical - Healthcare Information Services
$48.33
Up+$0.92 (+1.90%)
Updated Sep 16, 2026, 4:13 PM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.42B
- P/E ratio
- -19.76
- Dividend yield
- 0.00%
- 52-week range
- $20.13 – $51.78
- Volume
- 2.03M
- Avg. volume
- 452.7K
Price performance
HTFL price history
1M range · 20 trading sessions · Daily adjusted prices
HTFL closed at $48.33 after 20 trading sessions, up 6.85% for the selected period.
- Last close
- $48.33
- Period change
- +6.85%
- Period low
- $45.23
- Period high
- $50.43
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $49.28 | $50.44 | $48.19 | $48.33 | 2.03M |
| Sep 14, 2026 | $49.49 | $50.82 | $48.56 | $49.54 | 1.62M |
| Sep 11, 2026 | $46.11 | $50.23 | $45.60 | $49.88 | 2.22M |
| Sep 10, 2026 | $45.99 | $47.805 | $45.41 | $45.49 | 2.26M |
| Sep 9, 2026 | $47.25 | $48.26 | $45.50 | $46.67 | 1.42M |
| Sep 8, 2026 | $48.48 | $50.17 | $47.14 | $47.75 | 2.81M |
| Sep 4, 2026 | $49.74 | $49.8581 | $48.87 | $48.91 | 1.41M |
| Sep 3, 2026 | $50.63 | $51.00 | $48.10 | $49.71 | 1.47M |
| Sep 2, 2026 | $50.60 | $51.778 | $49.43 | $50.00 | 1.75M |
| Sep 1, 2026 | $50.28 | $50.9899 | $49.21 | $50.43 | 1.68M |
| Aug 31, 2026 | $47.68 | $50.99 | $47.13 | $50.39 | 2.63M |
| Aug 28, 2026 | $48.50 | $48.50 | $47.47 | $47.78 | 1.39M |
| Aug 27, 2026 | $48.92 | $50.44 | $48.03 | $48.10 | 1.5M |
| Aug 26, 2026 | $50.02 | $50.44 | $48.49 | $48.94 | 1.65M |
| Aug 25, 2026 | $50.95 | $51.19 | $49.8838 | $49.89 | 1.75M |
| Aug 24, 2026 | $49.75 | $50.85 | $48.65 | $50.20 | 2.33M |
| Aug 21, 2026 | $47.35 | $50.48 | $46.75 | $49.75 | 2.46M |
| Aug 20, 2026 | $45.90 | $47.95 | $45.60 | $46.80 | 1.99M |
| Aug 19, 2026 | $46.02 | $47.225 | $44.535 | $45.53 | 2.94M |
| Aug 18, 2026 | $41.50 | $45.33 | $40.67 | $45.23 | 4.17M |
Latest HTFL news
The latest Smart Investors Daily articles mentioning HTFL.
Stock researchCompany · Overview
HTFL research
Overview
Company profile and research snapshot.
Company profile
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $35.75
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 9, 2026 | UBS | Neutral | — |
| Aug 14, 2026 | Wells Fargo | Overweight | — |
| Aug 14, 2026 | JP Morgan | Overweight | — |
| Aug 14, 2026 | Piper Sandler | Overweight | — |
| Aug 14, 2026 | Morgan Stanley | Equal-Weight | — |
News briefing
No generated briefing is available yet.
Benzinga · Sep 9, 2026
UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55
UBS analyst Doug Schenkel initiates coverage on HeartFlow (NASDAQ:HTFL) with a Neutral rating and announces Price Target of $55.
Yahoo · Sep 6, 2026
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
The medical technology company reported a notable insider sale as its shares delivered a 59% one-year return.
SeekingAlpha · Sep 4, 2026
Baron SMID Cap ETF Q2 2026 Portfolio Activity
During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufacturer of stormwater and onsite wastewater management products.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
